John-Arne Rottingen, adjunct professor of global health and population at Harvard T.H. Chan School of Public Health and head of infectious disease control at the Norwegian Institute of Public Health, was awarded the Norwegian Fulbright Article of the Year Award for 2016. He received the award for the article Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial, published last year in The Lancet.
The prize (approximately $7,000) was presented on June 8, 2016 at the The Nobel Institute’s annual send-off ceremony for the Norwegian Fulbright grantees. Photos of Rottingen receiving the prize can be found here.
In addition, on June 14, 2016 it was announced that Rottingen will be the new Director General of the Research Council of Norway. Read more about his appointment and background here.
Learn more:
Experimental Ebola vaccine found highly effective in trial